NCT02942550View on ClinicalTrials.gov

Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
STEMIMorphineTicagrelorMethylnaltrexone
Interventions
DRUG

Methylnaltrexone bromide (Relistor®).

DRUG

Sodium Chloride 9mg/mL

Trial Locations (2)

Unknown

Karolinska University Hospital, Stockholm

Södersjukhuset (Stockholm South General Hospital), Stockholm

All Listed Sponsors
lead

Karolinska University Hospital

OTHER

NCT02942550 - Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients | Biotech Hunter | Biotech Hunter